A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

March 9, 2018

Study Completion Date

April 4, 2018

Conditions

Healthy

Interventions

DRUG

PF-06865571 Immediate release suspension

Suspension

DRUG

PF-06865571 Slow release MR tablets

Modified release tablets

DRUG

PF-06865571 Fast release MR tablets

Modified release tablets

DRUG

PF-06865571 Immediate release tablets

Immediate release tablets

Trial Locations (1)

Pfizer Clinical Research Unit, Brussels